Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41

Benzinga Newsdesk www.benzinga.com Positive 78.3%

Neg 0% Neu 0% Pos 78.3%

Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.